Guardant Health Stock Fundamentals
GH Stock | USD 17.96 0.27 1.53% |
Guardant Health fundamentals help investors to digest information that contributes to Guardant Health's financial success or failures. It also enables traders to predict the movement of Guardant Stock. The fundamental analysis module provides a way to measure Guardant Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guardant Health stock.
As of now, Guardant Health's Depreciation And Amortization is increasing as compared to previous years. The Guardant Health's current Interest Expense is estimated to increase to about 2.8 M, while Selling General Administrative is projected to decrease to under 118.7 M. Guardant | Select Account or Indicator |
Guardant Working Capital Analysis
Guardant Health's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Guardant Health Working Capital | 1.14 B |
Most of Guardant Health's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guardant Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Competition |
Guardant Capital Surpluse
Capital Surpluse |
|
According to the company's disclosures, Guardant Health has a Working Capital of 1.14 B. This is 168.1% higher than that of the Health Care Providers & Services sector and 146.38% higher than that of the Health Care industry. The working capital for all United States stocks is 22.8% higher than that of the company.
Guardant Health Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Guardant Health's current stock value. Our valuation model uses many indicators to compare Guardant Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Guardant Health competition to find correlations between indicators driving Guardant Health's intrinsic value. More Info.Guardant Health is rated below average in price to earning category among related companies. It is rated # 2 in current valuation category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Guardant Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Guardant Health's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Guardant Health's earnings, one of the primary drivers of an investment's value.Guardant Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guardant Health's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Guardant Health could also be used in its relative valuation, which is a method of valuing Guardant Health by comparing valuation metrics of similar companies.Guardant Health is currently under evaluation in number of employees category among related companies.
Guardant Fundamentals
Return On Equity | -4.38 | ||||
Return On Asset | -0.18 | ||||
Profit Margin | (0.85) % | ||||
Operating Margin | (0.73) % | ||||
Current Valuation | 2.37 B | ||||
Shares Outstanding | 121.71 M | ||||
Shares Owned By Insiders | 4.10 % | ||||
Shares Owned By Institutions | 92.19 % | ||||
Number Of Shares Shorted | 7.76 M | ||||
Price To Earning | (12.01) X | ||||
Price To Book | 13.77 X | ||||
Price To Sales | 3.88 X | ||||
Revenue | 563.95 M | ||||
Gross Profit | 293.21 M | ||||
EBITDA | (519.63 M) | ||||
Net Income | (479.45 M) | ||||
Cash And Equivalents | 853.69 M | ||||
Cash Per Share | 8.35 X | ||||
Total Debt | 1.35 B | ||||
Debt To Equity | 4.32 % | ||||
Current Ratio | 6.18 X | ||||
Book Value Per Share | 1.30 X | ||||
Cash Flow From Operations | (324.98 M) | ||||
Short Ratio | 3.91 X | ||||
Earnings Per Share | (4.28) X | ||||
Price To Earnings To Growth | (0.66) X | ||||
Target Price | 39.88 | ||||
Number Of Employees | 1.77 K | ||||
Beta | 0.87 | ||||
Market Capitalization | 2.19 B | ||||
Total Asset | 1.79 B | ||||
Retained Earnings | (2.14 B) | ||||
Working Capital | 1.14 B | ||||
Current Asset | 219.68 M | ||||
Current Liabilities | 24.24 M | ||||
Z Score | -0.59 | ||||
Net Asset | 1.79 B |
About Guardant Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guardant Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardant Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardant Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for 2024 | ||
Current Deferred Revenue | 18 M | 12.2 M | |
Total Revenue | 563.9 M | 282.4 M | |
Cost Of Revenue | 227.1 M | 238.4 M | |
Ebit Per Revenue | (1.00) | (1.05) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Guardant Health Piotroski F Score and Guardant Health Altman Z Score analysis. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.036 | Quarterly Revenue Growth 0.222 | Return On Assets (0.18) | Return On Equity (4.38) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.